Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Microbix Biosystems Inc. T.MBX

Alternate Symbol(s):  MBXBF

Microbix develops proprietary biological technology solutions for human health and well-being, with about 90 skilled employees and sales growing from a base of over $1 million per month. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs™) that support clinical lab... see more

Bullboard (TSX:MBX)

View:
Comment by rjc7on Dec 11, 2023 9:53am

RE:RE:Good sign

I hope you are right.  We've been down this road several times before.  It sure would be nice if we has some sort of an earnings "surprise" when they announce the Q results ...more  
Comment by wizzdumbon Dec 11, 2023 8:59am

RE:Good sign

Definitely, I think the 30's are gone forever. The rest of this year and next year are going to be incredible. Our patience is finally going to pay off. 
Post by rjc7on Dec 11, 2023 8:40am

Good sign

BIDS = ASK before the bell.
Comment by wizzdumbon Dec 10, 2023 7:41pm

RE:RE:RE:RE:RE:RE:RE:RE:StatCan just dropped a bombshell...

More testing definitely a positive for both QAPs and potentitally VTM. Long COVID includes increased risk of clotting which can be treated by Kinlytic. MBX is definitely not a pure COVID play but I it ...more  
Comment by prophetoffactzon Dec 10, 2023 4:41pm

RE:RE:RE:RE:RE:RE:RE:StatCan just dropped a bombshell...

The German Health Minister, himself a doctor, warns: “Covid remains dangerous. It's not a cold that you can safely catch every season. Rather, it affects the blood vessels or weakens the immune ...more  
Comment by prophetoffactzon Dec 10, 2023 4:37pm

RE:RE:RE:RE:RE:RE:StatCan just dropped a bombshell...

Canada's Chief Science Advisor says it's best not to get infected with COVID at all... @ChiefSciCan  ...more  
Comment by prophetoffactzon Dec 10, 2023 1:51pm

RE:RE:RE:RE:RE:StatCan just dropped a bombshell...

Sure looks like MBX could be a COVID play once again. If COVID is causing increased long term damage to the human population with each infection and damaging the human immune system creating a ...more  
Comment by tasman99on Dec 10, 2023 11:59am

RE:RE:RE:RE:RE:StatCan just dropped a bombshell...

how large of a bomb for mbx? fire cracker -1 london blitz -5 Hiroshima -10
Comment by prophetoffactzon Dec 08, 2023 5:20pm

RE:StatCan just dropped a bombshell...

Government policy flipped to 'don't test' for COVID... Given the increased cumulative risk of long COVID with each infection they may be forced to reevaluate policy. Widespread repeat ...more  
Comment by wizzdumbon Dec 08, 2023 5:11pm

RE:RE:RE:RE:RE:RE:RE:New Press Release - Microbix & BioGX Collaborate on real-time PCR Assays & Controls

I would expect them to be hitting their daily limit every day, and possibly seeing some large block share transactions soon.   
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities